Diagnostic Medical Systems (LTS:0RIA) EBIT : €-14.60 Mil (TTM As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Diagnostic Medical Systems EBIT?

Diagnostic Medical Systems's earnings before interest and taxes (EBIT) for the six months ended in Jun. 2024 was €-1.15 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Jun. 2024 was €-14.60 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Diagnostic Medical Systems's annualized ROC % for the quarter that ended in Jun. 2024 was -6.17%. Diagnostic Medical Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -17.90%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Diagnostic Medical Systems's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -50.05%.

Diagnostic Medical Systems EBIT Historical Data

The historical data trend for Diagnostic Medical Systems's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diagnostic Medical Systems EBIT Chart

Diagnostic Medical Systems Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBIT

Get a 7-Day Free Trial

-3.06

-3.31

-2.30

-6.42

-9.38

Diagnostic Medical Systems Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
EBIT	Get a 7-Day Free Trial															-4.00	-2.42	4.08	-13.46	-1.15

Competitive Comparison of Diagnostic Medical Systems's EBIT

For the Medical Devices subindustry, Diagnostic Medical Systems's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Diagnostic Medical Systems's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diagnostic Medical Systems's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Diagnostic Medical Systems's EV-to-EBIT falls into.

Diagnostic Medical Systems EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Jun. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was €-14.60 Mil.

Diagnostic Medical Systems (LTS:0RIA) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Diagnostic Medical Systems's annualized ROC % for the quarter that ended in Jun. 2024 is calculated as:

	ROC % (Q: Jun. 2024 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Dec. 2023 )	+	Invested Capital (Q: Jun. 2024 ))	/ count )
=	-2.096 * ( 1 - -1.39% )	/	( (34.041	+	34.85)	/ 2 )
=	-2.1251344	/	34.4455
=	-6.17 %

where

	Invested Capital		(Q: Dec. 2023 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	51.138	-	11.381	-	( 5.716	-	max(0, 22.017	-	31.672	+	5.716	))
=	34.041

	Invested Capital		(Q: Jun. 2024 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	49.614	-	12.152	-	( 2.612	-	max(0, 22.861	-	29.562	+	2.612	))
=	34.85

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

2. Joel Greenblatt's definition of Return on Capital:

Diagnostic Medical Systems's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Jun. 2024 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Dec. 2023		Q: Jun. 2024
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-2.292	/	( ( (5.125 + max(6.202, 0))	+	(4.794 + max(9.494, 0)) )	/	2 )
=	-2.292	/	( ( 11.327	+	14.288 )	/	2 )
=	-2.292	/	12.8075
=	-17.90 %

where Working Capital is:

	Working Capital		(Q: Dec. 2023 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(6.517	+	16.04	+	2.575)	-	(11.381	+	0	+	7.549)
=	6.202

	Working Capital		(Q: Jun. 2024 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(9.555	+	14.852	+	1.6)	-	(12.152	+	0	+	4.361)
=	9.494

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Jun. 2024) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Diagnostic Medical Systems's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Jun. 2024 )
	=	-14.601	/	29.175
	=	-50.05 %

Diagnostic Medical Systems EBIT Related Terms

Thank you for viewing the detailed overview of Diagnostic Medical Systems's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Diagnostic Medical Systems Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Diagnostic Medical Systems (LTS:0RIA) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

ALDMS:France

Address

9 Avenue du Canal Philippe, Gallargues le Montueux, FRA, FR-30660

Website

https://www.dms.com

Diagnostic Medical Systems is France's company engaged in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: Radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; and the Development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine.

Diagnostic Medical Systems Headlines

No Headlines